Alzahrani M, Maneno M, Daftary M, Wingate L, Ettienne E
Clin Med Insights Pediatr. 2018; 12:1179556518784300.
PMID: 30046262
PMC: 6055249.
DOI: 10.1177/1179556518784300.
Nurse-Lucas M, McGee L, Hawkins P, Swanston W, Akpaka P
Int J Infect Dis. 2016; 46:100-6.
PMID: 27062986
PMC: 5739879.
DOI: 10.1016/j.ijid.2016.04.005.
Link-Gelles R, Thomas A, Lynfield R, Petit S, Schaffner W, Harrison L
J Infect Dis. 2013; 208(8):1266-73.
PMID: 23852588
PMC: 3778966.
DOI: 10.1093/infdis/jit315.
Steinman M, Yang K, Byron S, Maselli J, Gonzales R
Am J Manag Care. 2009; 15(12):861-8.
PMID: 20001167
PMC: 2910590.
Coco A, Horst M, Gambler A
BMC Pediatr. 2009; 9:41.
PMID: 19552819
PMC: 2711950.
DOI: 10.1186/1471-2431-9-41.
Reduced susceptibility to penicillin among pneumococci causing invasive infection in children - Canada, 1991 to 1998.
Scheifele D, Halperin S, Pelletier L, Talbot J, Lovgren M, Vaudry W
Can J Infect Dis. 2007; 12(4):241-6.
PMID: 18159346
PMC: 2094824.
DOI: 10.1155/2001/984958.
Factors associated with antimicrobial resistance and mortality in pneumococcal bacteremia.
Neuman M, Kelley M, Harper M, File Jr T, Camargo Jr C
J Emerg Med. 2007; 32(4):349-57.
PMID: 17499686
PMC: 2034392.
DOI: 10.1016/j.jemermed.2006.08.014.
Development of adjunctive therapies for bacterial meningitis and lessons from knockout mice.
Paul R, Koedel U, Pfister H
Neurocrit Care. 2005; 2(3):313-24.
PMID: 16159083
DOI: 10.1385/NCC:2:3:313.
Hospital-reported pneumococcal susceptibility to penicillin.
Metlay J, Branas C, Fishman N
Emerg Infect Dis. 2004; 10(1):54-9.
PMID: 15078597
PMC: 3322741.
DOI: 10.3201/eid1001.030140.
Linezolid and vancomycin, alone and in combination with rifampin, compared with moxifloxacin against a multidrug-resistant and a vancomycin-tolerant Streptococcus pneumoniae strain in an in vitro pharmacodynamic model.
Cha R, Rybak M
Antimicrob Agents Chemother. 2003; 47(6):1984-7.
PMID: 12760880
PMC: 155816.
DOI: 10.1128/AAC.47.6.1984-1987.2003.
Increasing immunization rates among African-American adults.
J Natl Med Assoc. 2003; 95(4 Suppl):37S-48S.
PMID: 12749608
PMC: 2568313.
Using hospital antibiogram data to assess regional pneumococcal resistance to antibiotics.
Stein C, Weber D, Kelley M
Emerg Infect Dis. 2003; 9(2):211-6.
PMID: 12603992
PMC: 2901936.
DOI: 10.3201/eid0902.020123.
Prevention of Pneumococcal Meningitis.
Tan T
Curr Infect Dis Rep. 2002; 4(4):317-323.
PMID: 12126608
DOI: 10.1007/s11908-002-0024-0.
Sentinel surveillance: a reliable way to track antibiotic resistance in communities?.
Schrag S, Zell E, Schuchat A, Whitney C
Emerg Infect Dis. 2002; 8(5):496-502.
PMID: 11996685
PMC: 2732493.
DOI: 10.3201/eid0805.010268.
Treatment of Bacterial Meningitis.
Tunkel A, Scheld W
Curr Infect Dis Rep. 2002; 4(1):7-16.
PMID: 11853652
DOI: 10.1007/s11908-002-0062-7.
Antimicrobial treatment guidelines for acute bacterial rhinosinusitis.
Dis Mon. 2001; 47(11):537-585.
PMID: 11725257
PMC: 7094909.
DOI: 10.1016/s0011-5029(01)90004-5.
Two-year surveillance of antibiotic resistance in Streptococcus pneumoniae in four African cities.
Benbachir M, Benredjeb S, Boye C, Dosso M, Belabbes H, Kamoun A
Antimicrob Agents Chemother. 2001; 45(2):627-9.
PMID: 11158769
PMC: 90341.
DOI: 10.1128/AAC.45.2.627-629.2001.
Surveillance of invasive Streptococcus pneumoniae infection in the province of Quebec, Canada, from 1996 to 1998: serotype distribution, Antimicrobial susceptibility, and clinical characteristics.
Jette L, Delage G, Ringuette L, Allard R, De Wals P, Lamothe F
J Clin Microbiol. 2001; 39(2):733-7.
PMID: 11158138
PMC: 87807.
DOI: 10.1128/JCM.39.2.733-737.2001.
Impact of Antimicrobial Resistance on the Treatment of Invasive Pneumococcal Infections.
Rocha , Baleeiro , Tunkel
Curr Infect Dis Rep. 2000; 2(5):399-408.
PMID: 11095884
DOI: 10.1007/s11908-000-0066-0.
Gram-Positive Pneumonia.
Osiyemi , Dickinson
Curr Infect Dis Rep. 2000; 2(3):207-214.
PMID: 11095858
DOI: 10.1007/s11908-000-0037-5.